But most patients find their feet, and the trial data backs that up
Start gradually if you have been sedentary, and consult your GP before beginning vigorous exercise if you have cardiovascular risk factors
This dual actionreducing hunger and boosting metabolismsupports effective weight loss strategies
Novo Nordisk continues to promote and sell these products without any warning or discussion in their label regarding a risk of permanent vision loss. According to Gold, lawsuits allege that Novo Nordisk failed to warn patients and doctors about the risk of permanent blindness, even as new research found a significantly increased risk of NAION among semaglutide users
For patients, this is genuinely encouraging news: a second oral option with no fasting requirement and strong glycemic data would give prescribers a more flexible alternative particularly for people who struggle with the morning-routine demands of oral semaglutide
For a long time, glucagon was treated as the enemy of weight loss, since it raises blood sugar on its own